What happens when a pharmaceutical drug does more harm than good? These stories about the Avandia diabetes drug may answer that question.

Pharmaceutical Companies Perform Clinical Drug Trials in Other Countries

  "Prescription drugs kill some 200,000 Americans every year. Will that number go up, now that most clinical trials are conducted overseas...in places where regulation is virtually nonexistent, the F.D.A. doesn’t reach...?" A fascinating article recently discussed the increasingly common practice of  performing clinical drug trials outside of the United States for drugs planned to [...]

January 12th, 2011|Avandia Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Yaz Birth Control|Comments Off on Pharmaceutical Companies Perform Clinical Drug Trials in Other Countries

Court Denies Avandia Manufacturer’s Request to Exclude Experts

This week, Honorable Cynthia M. Rufe of the U.S. District Court for the Eastern District of Pennsylvania rejected GlaxoSmithKline's (GSK) request to exclude three plaintiff experts from testifying about the health risks associated with taking the diabetes drug, Avandia. The national Avandia multidistrict litigation  is coordinated in front of Judge Rufe.  Multidistrict Litigation (MDL) is [...]

January 5th, 2011|Avandia Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Court Denies Avandia Manufacturer’s Request to Exclude Experts

Drug Manufacturer Whistle-Blower Exposes Facility Failures

A segment on 60 Minutes discussed the story of Cheryl Eckard, who was the global quality assurance manager at GlaxoSmithKline (GSK).  Her job was to inspect plants to make sure drugs were manufactured properly and met government standards for purity. In 2002, Ms. Eckard was assigned to GSK's important Cidra, Puerto Rico, plant where 900 [...]

January 4th, 2011|Avandia Diabetes Drug|Comments Off on Drug Manufacturer Whistle-Blower Exposes Facility Failures

Brandi Firm Helps Draw Attention to Dangerous Drugs

For decades, the Brandi Law Firm has represented victims of defective pharmaceutical drugs and medical devices when their use has been shown to be unreasonably dangerous to users.  One similarity in all of these cases it that the adverse affects of these drugs was found after FDA approval through a high incidence of side effects. [...]

January 3rd, 2011|Avandia Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Yaz Birth Control|Comments Off on Brandi Firm Helps Draw Attention to Dangerous Drugs

Avandia Sales Restricted in U.S., Pulled from Market in Europe

The U.S. Food and Drug Administration announced that it will significantly restrict the use of the diabetes drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications.  These new restrictions are in response to data that suggest an elevated risk of cardiovascular events, such as heart attack and [...]

January 3rd, 2011|Avandia Diabetes Drug|Comments Off on Avandia Sales Restricted in U.S., Pulled from Market in Europe

FDA Placed Severe Use Restrictions for Avandia

The FDA announced in September that they are placing severe restrictions on the continuing use and prescription of Avandia.  The European Medicines Agency (Europe’s version of the FDA) went even further, banning the advertising, marketing, or sale of Avandia.  Under the FDA’s restrictions, a doctor will have to certify that their patient has tried all [...]

December 28th, 2010|Avandia Diabetes Drug|Comments Off on FDA Placed Severe Use Restrictions for Avandia

Avandia Diabetes Drug Lawsuit

Studies Show Avandia Increases Risk for Cardiac Problems Type two diabetics with high blood sugar levels are prone to serious health problems, such as hypertension, obesity, stroke, heart attack and heart disease. Avandia (generic name rosiglitazone maleate) has been given to many type two diabetes patients to keep their blood sugar levels below dangerous levels.  [...]

December 28th, 2010|Avandia Diabetes Drug|Comments Off on Avandia Diabetes Drug Lawsuit